BSE filing, NSE: BIJHANS. Summary written from the filing by ALFA Finder's alert engine.
Arvaya Healthcare Ltd: key numbers
- Share price
- ₹108.95
- Market cap
- ₹523.2 Cr
- Revenue (annual)
- ₹9.11 Cr
- Net profit (annual)
- ₹0.70 Cr
- P/E (TTM)
- 339.4×Sector 43.1×
- Promoter holding
- 30.62%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Arvaya Healthcare Ltd
All →Arvaya Healthcare Preferential Issue
Director Bidari Kotresh Anilkumar acquired 591,129 Arvaya Healthcare shares through a preferential offer. Holding rises to 4.45% from 3.58%.
Arvaya Healthcare Preferential Issue
Arvaya Healthcare allotted 38,71,854 equity shares at Rs.40 each to 47 SIGPL shareholders in a share swap. The allotment is valued at Rs.15.49 Crore.
- Value
- ₹15.49 Cr
Arvaya Healthcare Other Announcement
Arvaya Healthcare Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Listing Regulations.
Arvaya Healthcare Preferential Issue
Arvaya Healthcare received BSE in-principle approval to issue 38,71,854 equity shares at Rs. 40 each. This preferential allotment totals Rs. 15.49 Crore.
- Value
- ₹15.49 Cr
Arvaya Healthcare Annual General Meeting
Arvaya Healthcare Limited held its 41st Annual General Meeting on 21st September 2026, where members adopted financial statements and approved material related party transactions.
Arvaya Healthcare Merger & Restructuring Worth ₹0.8 Cr
Arvaya Healthcare has incorporated a wholly-owned subsidiary, Arvaya Insurance Broking Private Limited, for an investment of ₹0.80 Crore. This entity will provide insurance broking services.
- Value
- ₹0.80 Cr
Other board meeting date announcements
All →TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.
Salzer Electronics Board Meeting Date
Salzer Electronics Limited intimated a board meeting on 12 November 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. The trading window closes from 1 October to 14 November 2026.
Ekansh Concepts Board Meeting Date
Ekansh Concepts has scheduled a board meeting for November 5, 2026, to consider Q2 and H1 FY27 un-audited financial results. No figures are disclosed.
RateGain Travel Technologies Board Meeting Date
RateGain Travel Technologies will hold a board meeting on 5 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window closes from 1 October 2026 until 48 hours after results.
Tapi Fruit Processing Board Meeting Date
Tapi Fruit Processing will hold a board meeting on November 3, 2026 to consider unaudited standalone and consolidated half-yearly results for September 2026. Trading window closes from October 1 to November 5, 2026.